Medtronic has mitigated the impact of COVID-19 on its revenues by taking market share from competitors in key markets, including neurostimulation, drug-eluting stents, cardiac rhythm management and robotic spine surgery.
“As we head into our fourth quarter, we’re bullish on the recovery and our ability to return to growth and...






